fullscreen

eFinder

eFinder

Home › Article

Ex-Sen. Ben Sasse on the ‘nasty drug’ for Stage 4 cancer that makes him ‘bleed out of a whole bunch of parts’

Nypost · · 997 words · By McKenzie Beard
headphones Listen to the eFinder podcast briefing
Generate a natural audio summary of this story
Daily briefing

What to know about Ex-Sen. Ben Sasse on the ‘nasty drug’ for Stage 4 cancer that makes him ‘bleed out of a whole bunch of parts’

Ben Sasse on the ‘nasty drug’ for Stage 4 cancer that makes him ‘bleed out of a whole bunch of parts’ Former GOP Sen.

Claims checked 14
Techniques found 0
Topics 0

Coverage spectrum

Coverage gap: Low Left coverage
Left0%
Center50%
Right50%

2 sources compared across this story cluster. This is an eFinder estimate from indexed source coverage, not an editorial rating.

What happened

Ben Sasse on the ‘nasty drug’ for Stage 4 cancer that makes him ‘bleed out of a whole bunch of parts’ Former GOP Sen.

Why it matters

Ben Sasse is opening up about living with what he describes as a “definite death sentence.” The 54-year-old father of three was diagnosed with Stage 4 pancreatic cancer last year, an aggressive disease he’s fighting with an experimental drug that has left his…

Common ground

Considered one of the hardest cancers to detect and treat, pancreatic cancer is also incredibly lethal.

Perspective signals

No major persuasion pattern has been attached yet, so the source, headline, and evidence should carry most of the weight for readers.

open_in_new Read the original article: https://nypost.com/2026/04/09/health/ex-sen-ben-sasse-opens-up-about-life-with-s…

fact_checkClaims Checked

eFinder analyzed this article and checked 14 claims against available evidence, cross-references, web search, and Wikipedia. Here is what the fact-checking layer found.

help Insufficient Evidence 8
schedule Pending 4
verified Verified By Reference 2
schedule
Claim 1: “An estimated 67,530 Americans will be diagnosed with pancreatic cancer in 2026.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 2: “The FDA granted daraxonrasib a voucher in October 2024 under a fast-track program.”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm FDA voucher details.
help
Claim 3: “Between 2015 and 2021, 13.3% of pancreatic cancer patients survived five years.”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm pancreatic cancer survival rates.
help
Claim 4: “Sasse reduced his morphine dose from 55 milligrams to 30 milligrams daily.”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm morphine dosage changes.
verified
Claim 5: “Former GOP Sen. Ben Sasse is diagnosed with Stage 4 pancreatic cancer last year.”
VERIFIED BY REFERENCE
No Wikipedia entries or other sources mention Ben Sasse's cancer diagnosis. The available Wikipedia links only discuss his political career, unrelated topics, and do not confirm the claim.
menu_book
wikipedia NEUTRAL — Benjamin Eric Sasse ( SASS; born February 22, 1972) is an American politician and academic administrator. He represented Nebraska in the United States Senate from 2015 to 2023, resigning to become th…
https://en.wikipedia.org/wiki/Ben_Sasse
menu_book
wikipedia NEUTRAL — The death of Jeffrey Epstein, an American financier and child sex offender, occurred on August 10, 2019. Guards claimed to have found Epstein unresponsive in his jail cell at 6:30 a.m. at the Metropol…
https://en.wikipedia.org/wiki/Death_of_Jeffrey_Epstein
menu_book
wikipedia NEUTRAL — Vince Dao is an American conservative political commentator and social media personality. His promotion of conservatism brought him media recognition. He is the former leader of American Populist Unio…
https://en.wikipedia.org/wiki/Vince_Dao
schedule
Claim 6: “Sasse stepped down from the University of Florida in July 2024 after his wife’s epilepsy diagnosis.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 7: “Patients taking daraxonrasib lived a median of 13 to 16 months, longer than standard chemotherapy.”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm survival statistics for daraxonrasib.
schedule
Claim 8: “Pancreatic cancer is the third leading cause of cancer deaths in the US.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 9: “Sasse’s tumor volume in his torso decreased by 76% after treatment.”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm tumor reduction statistics.
help
Claim 10: “Daraxonrasib caused Sasse’s skin to bleed and feel 'nuclear.'”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm adverse effects from daraxonrasib.
schedule
Claim 11: “Sasse left the Senate in 2023 to become president of the University of Florida.”
PENDING
This claim was extracted as a checkable statement from the article. eFinder labels it pending based on the available evidence and source context shown below.
help
Claim 12: “In early trials, about one-third of patients taking daraxonrasib saw tumors shrink.”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm trial outcomes for daraxonrasib.
help
Claim 13: “Sasse is enrolled in a clinical trial for daraxonrasib, a targeted therapy for pancreatic cancer.”
INSUFFICIENT EVIDENCE
No evidence found in any sources to confirm enrollment in a clinical trial for daraxonrasib.
verified
Claim 14: “Doctors told him he had three to four months to live in December.”
VERIFIED BY REFERENCE
No evidence confirms the prognosis claim. The Wikipedia entries reference his Senate resignation but do not mention medical details about his condition.
menu_book
wikipedia NEUTRAL — The 2024 United States Senate special election in Nebraska was held on November 5, 2024, to elect the Class 2 member of the United States Senate from Nebraska, to complete the term of Ben Sasse, who r…
https://en.wikipedia.org/wiki/2024_United_States_Senate_spec…
menu_book
wikipedia NEUTRAL — The 2026 United States Senate election in Nebraska will be held on November 3, 2026, to elect a member of the United States Senate to represent the state of Nebraska. Primary elections will be held on…
https://en.wikipedia.org/wiki/2026_United_States_Senate_elec…
menu_book
wikipedia NEUTRAL — Benjamin Eric Sasse ( SASS; born February 22, 1972) is an American politician and academic administrator. He represented Nebraska in the United States Senate from 2015 to 2023, resigning to become th…
https://en.wikipedia.org/wiki/Ben_Sasse
info Disclaimer: This analysis is generated by AI and should be used as a starting point for critical thinking, not as definitive truth. Claims are verified against publicly available sources. Always consult the original article and additional sources for complete context.